Hepatic metastasectomy as a cytoreductive strategy for the treatment of liver metastases in breast cancer: review of literature.
The resection of liver metastases in breast cancer patients is a controversial therapeutical approach. No data of prospective randomized trials are available, thus evidence for the potential role of hepatic metastasectomy rests on retrospective studies with a small number of patients. Techniqual advances however have rendered hepatic metastasectomy safe and the long-term results of some studies possibly support the role of a surgical approach in selected patients.
Friedrich
M
M
Diesing
D
D
Schröer
A
A
D001943:Breast Neoplasms / Q000473:pathology*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery*; D009362:Neoplasm Metastasis; D012189:Retrospective Studies